The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 28, 2017
Filed:
Jan. 07, 2016
Applicant:
Allergan, Inc., Irvine, CA (US);
Inventors:
Rhett M. Schiffman, Laguna Beach, CA (US);
June Chen, San Juan Capistrano, CA (US);
Assignee:
ALLERGAN, INC., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5575 (2006.01); A61K 31/138 (2006.01); A61K 31/222 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/34 (2006.01); A61K 31/4045 (2006.01); A61K 31/4164 (2006.01); A61K 31/4704 (2006.01); A61K 31/498 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 31/5355 (2006.01); A61K 31/343 (2006.01); A61K 31/404 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5575 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 31/138 (2013.01); A61K 31/222 (2013.01); A61K 31/343 (2013.01); A61K 31/404 (2013.01); A61K 31/4164 (2013.01); A61K 31/4704 (2013.01); A61K 31/498 (2013.01); A61K 31/5355 (2013.01);
Abstract
Compositions containing a prostaglandin agent and a vasoconstrictor agent for ophthalmic applications are provided as well as methods of treating ophthalmic diseases using the same. In certain embodiments, the compositions and methods are useful for treating glaucoma without causing conjunctival hyperemia.